citalopram and lisdexamfetamine dimesylate

citalopram has been researched along with lisdexamfetamine dimesylate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cutler, AJ; Gao, J; Geibel, BB; Lasser, R; Patkar, AA; Richards, C; Sambunaris, A; Trivedi, MH1
Folgering, JH; Heins, MS; Hutson, PH1
Correa, M; Hutson, PH; Lopez-Cruz, L; Salamone, JD; Yohn, SE1
Brawman-Mintzer, O; Dauphin, M; Gao, J; Geibel, B; Madhoo, M; McIntyre, RS; Richards, C; Sambunaris, A; Weisler, R1
Dauphin, M; Geibel, B; Iosifescu, DV; Mago, R; Reynolds, J; Richards, C; Sarkis, E1

Trials

3 trial(s) available for citalopram and lisdexamfetamine dimesylate

ArticleYear
A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
    The Journal of clinical psychiatry, 2013, Volume: 74, Issue:8

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Central Nervous System Stimulants; Citalopram; Depressive Disorder, Major; Dextroamphetamine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Personality Inventory; Psychometrics; Young Adult

2013
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Journal of affective disorders, 2016, Volume: 206

    Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Least-Squares Analysis; Lisdexamfetamine Dimesylate; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2016
A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy.
    Journal of psychopharmacology (Oxford, England), 2017, Volume: 31, Issue:9

    Topics: Adult; Antidepressive Agents; Blood Pressure; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Venlafaxine Hydrochloride

2017

Other Studies

2 other study(ies) available for citalopram and lisdexamfetamine dimesylate

ArticleYear
Effects of lisdexamfetamine alone and in combination with s-citalopram on acetylcholine and histamine efflux in the rat pre-frontal cortex and ventral hippocampus.
    Journal of neurochemistry, 2015, Volume: 134, Issue:4

    Topics: Acetylcholine; Animals; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Citalopram; Dextroamphetamine; Drug Therapy, Combination; Hippocampus; Histamine Release; Lisdexamfetamine Dimesylate; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Treatment Outcome

2015
Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.
    Psychopharmacology, 2016, Volume: 233, Issue:6

    Topics: Animals; Behavior, Animal; Choice Behavior; Citalopram; Drug Interactions; Feeding Behavior; Lisdexamfetamine Dimesylate; Male; Motivation; Rats; Rats, Sprague-Dawley; Reward; Selective Serotonin Reuptake Inhibitors

2016